Difference between revisions of "National Alliance on Mental Illness"
(new page) |
(internal links tweeked) |
||
| Line 3: | Line 3: | ||
* [[Abbott Laboratories]] | * [[Abbott Laboratories]] | ||
* [[AstraZeneca]] Pharmaceuticals | * [[AstraZeneca]] Pharmaceuticals | ||
| − | * [[Bristol- | + | * [[Bristol-Myers Squibb]] Company |
* [[Eli Lilly and Company]] | * [[Eli Lilly and Company]] | ||
* [[Forest Laboratories Inc.]] | * [[Forest Laboratories Inc.]] | ||
* [[GlaxoSmithKline]] | * [[GlaxoSmithKline]] | ||
| − | * [[Janssen Pharmaceutica]] | + | * [[Janssen Pharmaceutica Inc.]] |
* [[McNeil Customer and Speciality Pharmaceuticals]] | * [[McNeil Customer and Speciality Pharmaceuticals]] | ||
* [[Otsuka America Pharmaceutical Inc.]] | * [[Otsuka America Pharmaceutical Inc.]] | ||
Revision as of 17:59, 9 January 2008
In 2004, the National Alliance on Mental Illness (NAMI) Annual Report lists the following Corporate Partners [1]...
- Abbott Laboratories
- AstraZeneca Pharmaceuticals
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Forest Laboratories Inc.
- GlaxoSmithKline
- Janssen Pharmaceutica Inc.
- McNeil Customer and Speciality Pharmaceuticals
- Otsuka America Pharmaceutical Inc.
- Pfizer
- Wyeth Pharmaceuticals
The Annual Report also states that support was given by
- [[National Association of State Mental Health Program Directors (NASHPD)
References
- ↑ National Alliance on Mental Illness Annual Report 2004 Accessed 9th January 2008
